Is taste and smell impairment irreversible in COVID-19 patients?
Özet
Objective: It is known that the COVID-19 disease, which has affected the whole world, causes symptoms, such as cough, fever, shortness of breath, muscle pain, fatigue, diarrhea, headache and sore throat, in addition to various clinical findings, such as loss of smell and taste. In this study, we aimed to reveal the loss of sense of taste and smell in COVID-19 patients and to investigate whether these sensory losses are permanent in the healing process of the disease. Method: This prospective study included 94 COVID-19 patients. Smell and taste tests were applied to all patients. Ten days after the first test, a second test was applied to the patients with an impaired sense of smell to compare the results. Results: Of the 94 patients, 55.3% were male, and the mean age was 53 ± 19.6 (21–90) years. There were 67 patients with smell and taste impairment, of whom 34 (50.7%) had smell impairment only, 3 (4.4%) had taste impairment only, and 30 (44.7%) had both smell and taste impairment. It was found that the smell scores of 55 patients with smell and taste impairment in the first evaluation were significantly higher at the second measurement; and their tasting period was significantly shortened compared to the first measurement (p˂0.001). Conclusion: COVID-19 patients may present to medical centers with a broad variety signs and symptoms. This study shows that impairment in the senses of smell and taste is common in this disease and strongly associated with COVID-19 infection. However, smell and taste impairment is mostly temporary and improves during the recovery period. © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Salcan, İsmail | |
| dc.contributor.author | Karakeçili, Faruk | |
| dc.contributor.author | Salcan, Sara | |
| dc.contributor.author | Ünver, Edhem | |
| dc.contributor.author | Akyüz, Sümeyye | |
| dc.contributor.author | Seçkin, Ender | |
| dc.contributor.author | Cingi, Cemal | |
| dc.date.accessioned | 2026-10-18T20:28:01.524621948Z | |
| dc.date.available | 2026-10-18T20:28:01.524621948Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Objective: It is known that the COVID-19 disease, which has affected the whole world, causes symptoms, such as cough, fever, shortness of breath, muscle pain, fatigue, diarrhea, headache and sore throat, in addition to various clinical findings, such as loss of smell and taste. In this study, we aimed to reveal the loss of sense of taste and smell in COVID-19 patients and to investigate whether these sensory losses are permanent in the healing process of the disease. Method: This prospective study included 94 COVID-19 patients. Smell and taste tests were applied to all patients. Ten days after the first test, a second test was applied to the patients with an impaired sense of smell to compare the results. Results: Of the 94 patients, 55.3% were male, and the mean age was 53 ± 19.6 (21–90) years. There were 67 patients with smell and taste impairment, of whom 34 (50.7%) had smell impairment only, 3 (4.4%) had taste impairment only, and 30 (44.7%) had both smell and taste impairment. It was found that the smell scores of 55 patients with smell and taste impairment in the first evaluation were significantly higher at the second measurement; and their tasting period was significantly shortened compared to the first measurement (p˂0.001). Conclusion: COVID-19 patients may present to medical centers with a broad variety signs and symptoms. This study shows that impairment in the senses of smell and taste is common in this disease and strongly associated with COVID-19 infection. However, smell and taste impairment is mostly temporary and improves during the recovery period. © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature. | |
| dc.identifier.doi | 10.1007/s00405-020-06560-0 | |
| dc.identifier.eissn | 1434-4726 | |
| dc.identifier.endpage | 415 | |
| dc.identifier.issn | 0937-4477 | |
| dc.identifier.issue | 2 | |
| dc.identifier.pmcid | PMC7801154 | |
| dc.identifier.pmid | 33432396 | |
| dc.identifier.scopus | 2-s2.0-85099305842 | |
| dc.identifier.startpage | 411 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/13186 | |
| dc.identifier.volume | 278 | |
| dc.identifier.wos | WOS:000607001800001 | |
| dc.language.iso | en | |
| dc.publisher | Springer Science and Business Media Deutschland GmbH | |
| dc.relation.ispartof | European Archives of Oto-Rhino-Laryngology | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | COVID-19 | |
| dc.subject | Prognosis | |
| dc.subject | Smell test | |
| dc.subject | Taste test | |
| dc.subject | Adult | |
| dc.subject | Aged | |
| dc.subject | Aged, 80 and over | |
| dc.subject | Female | |
| dc.subject | Humans | |
| dc.subject | Male | |
| dc.subject | Middle Aged | |
| dc.subject | Olfaction Disorders | |
| dc.subject | Prospective Studies | |
| dc.subject | SARS-CoV-2 | |
| dc.subject | Smell | |
| dc.subject | Taste | |
| dc.subject | Taste Disorders | |
| dc.subject | Young Adult | |
| dc.subject | ageusia | |
| dc.subject | anosmia | |
| dc.subject | Article | |
| dc.subject | bitter taste | |
| dc.subject | coronavirus disease 2019 | |
| dc.subject | disease course | |
| dc.subject | human | |
| dc.subject | major clinical study | |
| dc.subject | olfactory discrimination | |
| dc.subject | priority journal | |
| dc.subject | prospective study | |
| dc.subject | saltiness | |
| dc.title | Is taste and smell impairment irreversible in COVID-19 patients? | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 17 | |
| rdl.citation.wos | 15 | |
| rdl.department | Department of Otorhinolaryngology, Faculty of Medicine, Mengücek Training and Research Hospital, Erzincan Binali Yıldırım University, Erzincan, Turkey. | Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. | Department of Public Health, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. | Department of Chest Disease, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. ethemunver@hotmail.com. | Department of Medical Microbiology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. | Department of Otorhinolaryngology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. | |
| rdl.oa.status | green | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
